The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
when the results are officially announced I'll happily log on and share the information with the many thousands of participants there. Just think of the good you will be bringing to many thousands of peoples lives by just doing that. Wont be taking advantage it will really be helping in a big way, and if others do likewise even better.
I have been a member of some of those forums for a little while, and its pretty upsetting to read some peoples issues coupled with the side effects they endure with various drugs they have to put up with just to get partial relief in many cases.
So I'm pretty proud to be able to invest in a company that stands to help so many people. Members here could also help in this aspect by spreading the good news, when it officially arrives.
when the results are officially announced I'll happily log on and share the information with the many thousands of participants there. Just think of the good you will be bringing to many thousands of peoples lives by just doing that. Wont be taking advantage it will really be helping in a big way, and if others do likewise even better.
I have been a member of some of those forums for a little while, and its pretty upsetting to read some peoples issues coupled with the side effects they endure with various drugs they have to put up with just to get partial relief in many cases.
So I'm pretty proud to be able to invest in a company that stands to help so many people. Members here could also help in this aspect by spreading the good news, when it officially arrives.
Yes agreed mathurin, and if the results are positive the extensive online communities should help many of those who suffer to quickly hear about a new and natural product that will help alleviate their symptoms!
Following your message I took a quick look at the Psoriasis website to see what research they had done . My clear impression from sufferers was the lack of psoriasis expertise from dermatologists and a lack of awareness for the psychological damage which flare ups can create . What is absolutely clear is the fact that sufferers at the present time have no real solution and great difficulty to get advice . In conclusion if the results of the study are truly positive - then game over .
Why do people assume it is pis hopping from Skin to Opti when there have been several RNS's informing that Seneca Partners Limited, the second biggest Skin Shareholder, reducing their holding on the back of recent rises to keep their portfolio in balance?
For what it is worth, as a holder of shares in both companies, 75%/25% in favour of skin by value, I do not see the results being a risk event, more a boost to the sp. The risk lies in hitting the forecast initial 25000 customers, and before people jump up and down, have a look at the UK psoriasis society forum and see how much excitement exists on their discussion forum; in fact find me a single thread. Now that is not to say Stuart's projections are wrong, merely that awareness amongst that particular community at the moment appears very low
https://www.psoriasis-association.org.uk/forums/
Hi, if it's someone moving out of SBTX and into Opti, might it be de-risking ahead of the study results?
I guess the impact of the results on the SBTX SP will be far greater than the impact on the Opti results, although it will still have an impact on Opti as well. So by moving over they've banked the recent rise of SBTX and reduced the potential downside of poor study results, sacrificing the potential upside of SBTX to reduce the risk? I'm sure there is an easier way to articulate that :)
Great to see the rebound starting today from the small retrace recently, but many investors here like me are very pleased with the opportunity to top up and those shares are already showing in the black.
Still dont fully understand the rational behind those sells we saw, only one that might make sense was if it was from the OPTI directors, who offloaded some so they could buy some OPTI stock today.
Hi Mathurin,
Guess thats the advantage of being at the cutting edge of probiotics and gut health. SBTX and its parent company have protected and fortified the IP and most effective and beneficial bacteria that they have researched and found. There are records of other strains IP being sold but that was for a cool 70M if I'm not mistaken.
That's a huge value that Mr.Market is not looking at with OPTI and SBTX, and once we see competition take off, or even a take over from a very big global player small but very significant facts like these will come to the fore. OPTI spent a long time protecting its products (and SBTX's), with this vision in mind. Steven should be congratulated on this for his foresight.
I have spent much time on the French biotech market where research and trials run into years requiring huge patience. What interests me to know is what competition is lining up to produce probiotic products which have the enormous advantage of not requiring trials .I realise that the current Skinbiotix product has taken very many years to research and so we are at a very fortuitous moment in time .
64p paid.
£17.57K buy going through at just below 64p.
Nice.